US 9622983
Sustained-release formulations of topiramate
granted A61KA61K31/357A61K31/7048
Quick answer
US patent 9622983 (Sustained-release formulations of topiramate) held by Supernus Pharmaceuticals, Inc. expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Supernus Pharmaceuticals, Inc.
- Grant date
- Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/357, A61K31/7048, A61K45/06, A61K47/6951